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Introduction 5 140
Acr-phage amplification is density-dependent 141 Having ruled out that the observed tipping points by Acr-phage are the result of escape 142 phage evolution, we hypothesized that the density of Acr-phage may determine the 143 observed tipping points. To test this hypothesis, we examined whether amplification of 144 Acr-phage was density-dependent without altering the initial amount of phage. This 145 was done by measuring amplification of the same initial amount of phage on different 146 volumes of bacterial host culture, generating a High Phage-Density (HPD) condition 147 (small volume), and a Low Phage-Density (LPD) condition (large volume). Phage 148 amplification was greater on CRISPR-KO hosts under LPD conditions compared to 149 HPD conditions, simply because the bacterial densities are constant across the 150 treatments and the large volume therefore contains proportionally more bacteria on 151 which the phage can replicate ( Fig. 3; F1 ,22 = 10.54, p < 0.01). However, when Acr-152 phages were amplified on CRISPR-resistant hosts (BIM2), the greatest level of 153 amplification was observed under HPD conditions ( Fig. 3; F1 ,22 = 59.68, p < 0.0001),
154
demonstrating that Acr-phage amplification is indeed positively density-dependent.
155
Furthermore, the level of amplification of Acr-phages on this CRISPR-resistant host 156 was independent of the presence of high amounts of phage DMS3mvir, which lacks 157 an acrF gene, demonstrating that the observed density-dependence is specifically 158 linked to the density of acr genes, and cannot be explained by saturation of CRISPR-
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Cas complexes with targeted phage genomes ( Fig. S2) 
172
that accounts for the efficacy of CRISPR resistance in the bacteria ( increases with 173 the number of spacers targeting the phage) as well as the efficacy of Acr in the 174 phage (consistent with the EOP data). In this form, the model predicts that upon 175 infection of 10 6 CRISPR-resistant bacteria phage expressing a strong Acr can always 6 amplify, regardless of the initial phage density (Fig. S3, ϕ=0 .67, purple line), whereas 177 phage with a weak Acr can never amplify ( Fig. S3, ϕ=0 .6 and ϕ=0.5, magenta and 178 green lines respectively; grey lines correspond to the initial amount of phage and 179 values below this line indicate a lack of phage amplification). Given that these model 180 predictions are inconsistent with our experimental data, we then extended the model 181 by incorporating the assumption that during failed infections some Acr is produced that 182 causes the surviving host to enter a "suppressed" state ("S"). This immunosuppression 183 decreases the efficacy of host resistance and allows following phages to exploit these 184 bacteria (Fig. 4a) . Crucially, if the immunosuppressed state is assumed, the model 185 predicts epidemiological tipping points and, in accordance with our empirical data, 186 these tipping points occur at MOIs far below 1 (Fig. 4b) . Besides, our experimental 187 observations that the position of the tipping points shifts when Acrs are weaker or host 188 resistance is stronger ( Fig. 2) are fully explained by our model when we vary the effect 189 of the efficacy of the Acr in the phage (Fig. 4b) , or the efficacy of CRISPR 190 resistance in the bacteria (i.e., the number of spacers in the host targeting the phage, 191 Fig. 4c ). Moreover, longer periods of immunosuppression shift the tipping points to 192 lower phage densities, as it increases the probability that a host will be re-infected 193 when it is still in the immunosuppressed state ( Fig. 4d , indicated by g). This model 194 therefore predicts that Acr-phage infections can cause CRISPR-resistant bacteria to 195 become immunosuppressed, allowing cooperation between sequentially infecting Acr-196 phages to overcome CRISPR immunity, which is a critical factor in determining 197 whether Acr-phages can amplify. 
235
phages that are produced from successful infections outweighs the loss of Acr-phages 236 due to unsuccessful infections, causing the epidemic to take off (Fig. S4b ). If this 237 critical threshold is not reached, the Acr-phage goes extinct and immunosuppressed 238 hosts revert to their resistant state (Fig. S4a) .
239
The long-term immunosuppression following a failed infection of Acr-phage is 240 cooperative in that it provides a benefit to Acr-phages that sequentially infect the same 241 host to overcome CRISPR resistance. Future studies aimed at measuring the costs 242 and benefits associated with phage-encoded Acr genes and their natural ecology will 243 be critical to understanding the evolutionary drivers and stability of Acr-phage 
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aeruginosa UCBPP-PA14 csy3::LacZ (referred to as CRISPR-KO, which carries a 463 disruption of an essential cas gene and can therefore not evolve CRISPR immunity),
464
have been described in (Cady et al. 2012; Westra et al. 2015; van Houte et al. 2016 ).
465
The BIM2 strain (carrying two spacers targeting DMS3mvir) has been described in 466 (Westra et al. 2015) . The BIM5 strain (carrying 5 spacers targeting DMS3mvir) was 467 generated by challenging PA14 BIM2 bacteria with escape phage in multiple rounds,
468
giving rise to BIM3, BIM4 and finally BIM5. 
